Contraline is a clinical-stage biotechnology company focused on innovation in male reproductive health. The company is advancing both hormonal and non-hormonal approaches to expand contraceptive options for men and couples globally.
Following its recently completed Series B financing, Contraline is entering a pivotal stage of growth as it advances toward late-stage clinical development, regulatory milestones, expanded manufacturing, and future product launch.
Serve as Contraline’s senior regulatory leader, responsible for developing and executing global regulatory strategies across a growing pipeline of innovative therapeutics and devices.